Eli Lilly logo is shown on one of the company's offices in San Diego, California, U.S., September 17, 2020.
Eli Lilly on Tuesday reported first-quarter adjusted profit that topped Wall Street's expectations and hiked its full-year guidance on strong sales of its blockbuster diabetes drug Mounjaro and newly launched weight loss treatment Zepbound.
Eli Lilly also expects revenue for the year to come in between $42.4 billion and $43.6 billion, an increase of $2 billion at either end of the range.
Shares of Eli Lilly jumped almost 8% in premarket trading Tuesday.
With a market cap of about $700 billion, Eli Lilly is the largest pharmaceutical company based in the U.S.
Persons:
Eli Lilly, LSEG, They're
Organizations:
Analysts, LSEG
Locations:
San Diego , California, U.S